Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, and Triangle Residential Options for Substance Abusers, Inc. (TROSA), a Durham-based innovative, multi-year residential program that enables substance abusers to be productive, recovering individuals by providing comprehensive treatment, work-based vocational training, education, and continuing care, have announced Alcami’s donation of $10,000. Alcami’s gift will fund TROSA’s technology needs for its recently established Comprehensive Care Center.

“Alcami is proud to support TROSA, an incredible, nationally-recognized care provider with a revered standing in the recovery and public health communities, and a true source of hope for people struggling with addiction,” said Alcami CEO, President and Chairman, Dr Stephan Kutzer. “We share TROSA’s compassion for the community and believe an investment in their organization is an investment in saving lives.”

Alcami’s donation will properly outfit TROSA’s medical department with computers, monitors, and accessories for its exam rooms, which will enable its medical specialists to quickly assess and document treatment for residents. It will also equip their medical office bullpen, where residents receive vocational training. The upgrades will optimize TROSA’s overall operations, increase efficiency, and ultimately improve the physical and mental health outcomes of individuals enrolled in their long-term recovery program.

“TROSA is so thankful for this gift from Alcami,” said TROSA Founder, President and CEO, Kevin McDonald. “At TROSA, we treat the whole person, including the physical and mental health needs of our residents in recovery. Funding our medical team’s urgent technology needs for the new TROSA Comprehensive Care Center will greatly enhance our work. Now, thanks to Alcami, we can take full advantage of the outstanding talents of our health specialists and better serve our residents.”

Alcami’s Durham, North Carolina global headquarters and development services laboratories are situated in the heart of Research Triangle Park (RTP), a region known for its cutting-edge innovation, invention, and medical advances. The growing facility, currently undergoing a technology expansion into biotherapeutics, specializes in abuse deterrence studies to reduce or eliminate the abuse and misuse of opioids. Furthermore, Alcami supports the industry and patients with the development and manufacture of opioid addiction therapeutic treatments.